Malignant thymoma in a patient with growth hormone deficiency during growth hormone therapy

T Hasegawa; Y Hasegawa; S Koto; T Aso; Y Tsuchiya; A Hayashi; H Ishida; Y Morikawa

doi:10.1007/BF02073374

Malignant thymoma in a patient with growth hormone deficiency during growth hormone therapy

Eur J Pediatr. 1993 Oct;152(10):802-4. doi: 10.1007/BF02073374.

Authors

T Hasegawa¹, Y Hasegawa, S Koto, T Aso, Y Tsuchiya, A Hayashi, H Ishida, Y Morikawa

Affiliation

¹ Division of Endocrinology and Metabolism, Tokyo Metropolitan Kiyose Children's Hospital, Japan.

PMID: 8223780
DOI: 10.1007/BF02073374

Abstract

Malignant thymoma was found in an 8-year-old Japanese boy with growth hormone (GH) deficiency who had received GH therapy for 3 years and 5 months. There may be a possible relationship between the occurrence of malignant thymoma and GH therapy.

Publication types

Case Reports

MeSH terms

Child
Growth Hormone / adverse effects*
Growth Hormone / deficiency*
Growth Hormone / therapeutic use
Humans
Male
Thymoma / chemically induced*
Thymoma / pathology
Thymus Neoplasms / chemically induced*
Thymus Neoplasms / pathology

Substances

Growth Hormone